Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adolfo de la Fuente

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
International Journal of Cardiology|July 11, 2006
Electrocardiographic findings after acute absinthe intoxicationJuan Benezet-Mazuecos, Adolfo de la Fuente
American Journal of Hematology|June 19, 2007
Loeffler endocarditis: what have we learned?Juan Benezet-Mazuecos, Adolfo de la Fuente, Pedro Marcos-Alberca, et al.
Circulation|December 13, 2006
Images in cardiovascular medicine. Early differential resolution of right and left ventricular obliteration in Löffler endocarditis after chemotherapy and anticoagulationJuan Benezet-Mazuecos, Pedro Marcos-Alberca, Jerónimo Farré, et al.
Experimental Hematology & Oncology|March 14, 2015
Long-term survival in a patient with progressive multifocal leukoencephalopathy after therapy with rituximab, fludarabine and cyclophosphamide for chronic lymphocytic leukemiaHeidys Garrote, Adolfo de la Fuente, Raquel Oña, et al.
Haematologica|November 16, 2016
Guidelines for diagnosis, prevention and management of central nervous system involvement in diffuse large B-cell lymphoma patients by the Spanish Lymphoma Group (GELTAMO)Francisco-Javier Peñalver, Juan-Manuel Sancho, Adolfo de la Fuente, et al.
Clinicoeconomics and Outcomes Research : CEOR|April 29, 2021
Cost-Effectiveness Analysis of Gemtuzumab Ozogamicin for First-Line Treatment of Patients with Cd-33 Positive Acute Myeloid Leukaemia in SpainMaria Mareque, Pau Montesinos, Patricia Font, et al.
Leukemia & Lymphoma|October 24, 2025
Optimizing capillary leak syndrome prevention and management in patients receiving tagraxofusp for blastic plasmacytoid dendritic cell neoplasmAndrew A Lane, Cristina Papayannidis, Emanuele Angelucci, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 11, 2022
Incidence and management of patients with methotrexate delayed elimination in the clinical practice: A Delphi studyLuis Gros, Alicia Roldán, Almudena Cabero-Martínez, et al.
Expert Opinion on Biological Therapy|December 25, 2025
The role of targeted therapies in blastic plasmacytoid dendritic cell neoplasmRoberta S Azevedo, Zohra Nooruddin, Sumeet Bhatia, et al.
Scientific Reports|May 14, 2024
Stellae-123 gene expression signature improved risk stratification in taiwanese acute myeloid leukemia patientsYu-Hung Wang, Adrián Mosquera Orgueira, Chien-Chin Lin, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
International Journal of Cardiology|July 11, 2006
Electrocardiographic findings after acute absinthe intoxicationJuan Benezet-Mazuecos, Adolfo de la Fuente
American Journal of Hematology|June 19, 2007
Loeffler endocarditis: what have we learned?Juan Benezet-Mazuecos, Adolfo de la Fuente, Pedro Marcos-Alberca, et al.
Circulation|December 13, 2006
Images in cardiovascular medicine. Early differential resolution of right and left ventricular obliteration in Löffler endocarditis after chemotherapy and anticoagulationJuan Benezet-Mazuecos, Pedro Marcos-Alberca, Jerónimo Farré, et al.
Experimental Hematology & Oncology|March 14, 2015
Long-term survival in a patient with progressive multifocal leukoencephalopathy after therapy with rituximab, fludarabine and cyclophosphamide for chronic lymphocytic leukemiaHeidys Garrote, Adolfo de la Fuente, Raquel Oña, et al.
Haematologica|November 16, 2016
Guidelines for diagnosis, prevention and management of central nervous system involvement in diffuse large B-cell lymphoma patients by the Spanish Lymphoma Group (GELTAMO)Francisco-Javier Peñalver, Juan-Manuel Sancho, Adolfo de la Fuente, et al.
Clinicoeconomics and Outcomes Research : CEOR|April 29, 2021
Cost-Effectiveness Analysis of Gemtuzumab Ozogamicin for First-Line Treatment of Patients with Cd-33 Positive Acute Myeloid Leukaemia in SpainMaria Mareque, Pau Montesinos, Patricia Font, et al.
Leukemia & Lymphoma|October 24, 2025
Optimizing capillary leak syndrome prevention and management in patients receiving tagraxofusp for blastic plasmacytoid dendritic cell neoplasmAndrew A Lane, Cristina Papayannidis, Emanuele Angelucci, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 11, 2022
Incidence and management of patients with methotrexate delayed elimination in the clinical practice: A Delphi studyLuis Gros, Alicia Roldán, Almudena Cabero-Martínez, et al.
Expert Opinion on Biological Therapy|December 25, 2025
The role of targeted therapies in blastic plasmacytoid dendritic cell neoplasmRoberta S Azevedo, Zohra Nooruddin, Sumeet Bhatia, et al.
Scientific Reports|May 14, 2024
Stellae-123 gene expression signature improved risk stratification in taiwanese acute myeloid leukemia patientsYu-Hung Wang, Adrián Mosquera Orgueira, Chien-Chin Lin, et al.
Pageof 4